Dr. Michael Alberti serves as an Assistant Professor in Pathology at the University of Colorado Denver - Anschutz Medical Campus, where he is recognized as a thought leader in his field. His deep academic roots, including degrees in Biochemistry & Molecular Biology, Medicine, and Viral Gene Therapy, have paved the way for a career dedicated to advancing our understanding of genetics and gene therapy. Dr. Alberti's research delves particularly into the complex roles played by myeloid cells and adenoviridae, making significant contributions to this vital area of knowledge.
A key focus of Dr. Alberti's work is his role as Principal Investigator for the NIH-funded project K08HL159354. This research is centered on exploring the distinct ways that U2AF1 mutations contribute to the development of myelodysplastic syndromes. Through this project, he demonstrates a strong commitment to uncovering the intricate links between genetic changes and disease, with the ultimate goal of identifying innovative therapeutic strategies that could transform patient care.
Beyond his direct research, Dr. Alberti has substantially enriched the scientific literature. He has authored and co-authored a wealth of publications featured in highly respected journals, including the New England Journal of Medicine, Journal of Clinical Investigation, and Leukemia. These publications not only showcase his expertise but also underscore the meaningful impact his research has had within the broader scientific community.
Dr. Alberti's passion for his field extends beyond his own discoveries; it is also evident in his dedication to nurturing the next generation of scientists. His ongoing work continues to inspire and help shape the future direction of genetic therapy. This blend of impactful research and commitment to mentorship solidifies his standing as a highly respected figure in both academic and medical research circles.
, 1730-01-01
, 258-271, 2017-10-01
, 274-291, 2018-11-01
, 141-153, 2016-07-01
, 597-612, 2015-03-01
, 109016, 2024-08-01
, 272-279, 2017-10-01
, 230-240, 2018-01-01
, 107227, 2020-11-01
, 8-16, 2015-12-01
The University of Colorado Anschutz Medical Campus (CU Anschutz) is the academic health sciences campus of the University of Colorado in Aurora, Colorado. It is the largest academic health center in the Rocky Mountain region, and is home to six health sciences schools and colleges, as well as the graduate school for various fields in the biological and biomedical sciences. The campus also includes the 184-acre (0.74 km2) Fitzsimons Innovation Community, UCHealth University of Colorado Hospital, Children's Hospital Colorado, the Rocky Mountain Regional Veterans Affairs hospital, and a residential/retail town center known as 21 Fitzsimons.
The Department of Pathology at the University of Colorado Denver, situated within the School of Medicine on the Anschutz Medical Campus in Aurora, Colorado, serves a vital role in healthcare through its comprehensive programs spanning anatomical pathology, clinical pathology, and laboratory medicine. Dedicated to providing excellent patient care, robust education, and impactful research, it functions as a key component of the region's only comprehensive academic health sciences center. Clinical practice and training are primarily centered at University of Colorado Hospital, Children's Hospital Colorado, and the Rocky Mountain Regional VA Medical Center on the Anschutz campus, alongside an affiliation with Denver Health Hospital. The department also operates specialized referral laboratories, including the Colorado Molecular Correlates Lab and the Colorado Genetics Laboratory, utilizing advanced molecular and genomic methods to support personalized medicine and comprehensive cancer programs.
View Pathology
